New Client - Medically Managed Weight Loss Consult

Service Description

Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the U.S. Food and Drug Administration (FDA). The process by which the compounded drugs are manufactured have not been reviewed by the FDA. A prescription is required. Individual results may vary. No specific weight loss, health outcome, or therapeutic result is guaranteed. Any references to FDA-approved medications are provided for informational purposes only. Compounded medications provided by RevIVeU are not identical to, not equivalent to, and not represented as bioequivalent to any FDA-approved or brand-name medication. RevIVeU is not affiliated with, endorsed by, or sponsored by any pharmaceutical manufacturer or brand-name drug. All treatment decisions are made exclusively by licensed medical providers based on individual patient evaluation, medical history, and independent clinical judgment. Marketing language is general in nature and should not be interpreted as a promise, guarantee, or representation of specific outcomes. Statements made on this website, in advertisements, or on social media have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Testimonials and before-and-after images reflect individual experiences and do not represent typical or expected results. Information provided by RevIVeU is for educational purposes only and does not constitute medical advice. Patients should consult with a licensed healthcare provider to determine appropriate treatment where FDA approved products containing semaglutide are available. Compounded medications are prepared by state-licensed pharmacies pursuant to patient-specific prescriptions.